Actively Recruiting
Dexmedetomidine and Bupivacaine Intra-articular for Postoperative Analgesia After Knee Arthroscopic Surgery
Led by Al-Azhar University · Updated on 2025-04-22
75
Participants Needed
2
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study to compare the analgesic effects of intraarticular dexmedetomidine added to bupivacaine with those of bupivacaine alone after knee arthroscopy
CONDITIONS
Official Title
Dexmedetomidine and Bupivacaine Intra-articular for Postoperative Analgesia After Knee Arthroscopic Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- ASA I-II patients
- Either sex
- Aged 18-65 years
- Candidates for anterior cruciate ligament (ACL) reconstruction by knee arthroscopy
You will not qualify if you...
- Patients with kidney failure, liver failure, valvular or ischemic heart disease, high blood pressure, diabetes, infection, or malignancy
- History of coagulation diseases or drug allergies to the study medications
- Use of NSAIDs or analgesics within 24 hours before surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Al-Azhar University
Asyut, Egypt, 71523
Actively Recruiting
2
Al-Azhar University
Asyut, Egypt
Not Yet Recruiting
Research Team
M
Mohamed A. Mahmoud, MD
CONTACT
W
Warda D.K. Ali, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here